Monsanto: $86.74M Glyphosate Award Lacks ‘Substantial Evidence,’ Warrants Reversal

(February 11, 2020, 11:38 AM EST) -- SAN FRANCISCO — Monsanto Co. on Feb. 7 filed a brief in California appellate court contending that an $86,742,310 glyphosate cancer verdict against the company should be reversed because the claims...
To view the full article, register now.